Blue Horseshoe Stocks: Bottom-Play, Options & More

EnteroMedics Inc. ETRM

ETRM is the first in a group of plays that we’ve been familiar with in the past, that we’d like to circle back around to this morning.

We never stop looking out for stocks giving a bounce signal off of their 52-week lows, and ETRM raised that flag yesterday. The stock hit a new annual low (.123) as the short week kicked off on Tuesday, and yesterday’s session showed a clear rebound , trading between .14-.15, so we’ll just want to keep our eyes peeled for a mid-to-extended term recovery.


GW Pharmaceuticals plc GWPH

GWPH is another stock that we’ve had experiences with in the past, and today we’ve spotted a possible opportunity to take advantage of it once again.

On the flip-side of the coin from the previously mentioned play, GWPH has just hit its highest PPS since last October (104.58) yesterday on an epic single-day surge. That’s quite an impressive jump over its levels the last time we mentioned it in our reports, when it was trading just above $80.

Additionally, looking back over GWPH’s track record, it seems every time the stock makes a major move to the upside, there’s always a commensurate consolidation that follows. For this reason, we’re going to signal a range of extended-term puts in the GWPH options chain to track over the coming days and weeks.

Our four potential targets are going to be the GWPH 10/21 $105-90 Puts.


Rite Aid Corp. RAD

Also among stocks we’ve tracked at various times and for various reasons in the past, is RAD, though it has been quite some time since we last had our eyes on it closely.

Today we’ve been provided with an update on the status of the pending buyout of the company by Walgreens Boots Alliance (WBA) (>>View PR)

We’ll be watching the stock which is presently trading at a low multiple in the 8.30-range, as well as an options idea; the RAD Weekly $7.50 and $8 Calls, with the possibility of rolling up to the $8.50′s if and when the stock breaks its premarket high 8.42.


Extended Watchlist:
JNSH, TURV, PCYS, SFRX

Blue Horseshoe Stocks: MDCN Recap, Options Idea & More

Medican Enterprises, Inc. MDCN

In yesterday morning’s premarket report we took note of MDCN’s rebound off of a relative bottom, and speculated that the momentum built up in Tuesday’s session could carry over into added gains.

That certainly proved to be the case, as MDCN spiked heavily from its early low of .0024, running as high as .0039 shortly before 11:30AM. It marked an intraday move which provided gain opportunities of up to 62% before pulling back into the close of .0022.

We’ll go ahead and monitor this one for the remainder of the week for any potential bounce-play chances that might arise when it finds solid support. We’ll look for that to occur at or above Tuesday’s low of .0015.


Isis Pharmaceuticals, Inc. ISIS – Options Idea

ISIS appears to be in full-on breakout mode this morning, and as a result we thought we’d formulate an idea to take advantage of this via the options chain.

Given the current price and conditions caused by this morning’s catalyst (link to PR below), we’re going to be tracking the activity in the Weekly $70-73 Calls for potential intraday flip opportunities.


Extended Watchlist:
PTBI, RAD, SFUN, ATOS, AGEN, ASTI

Blue Horseshoe Stocks: PBR, INO, RAD Reviews & More

Petroleo Brasiliero, S.A. (Petrobras) PBR – Options

PBR has continued to perform this week after we caught it coming off its 52-week lows two Thursday’s ago. At that time one of our main areas of interest was the 05/01 $6.50 Calls, which we subsequently observed trading at a low of .22. This week they’ve attained a high of .71, marking off a tidy 222% move.

The last time we touched upon PBR options on Monday morning, it was in the process of pushing even higher, so we suggested the possibility of rolling up our strike price to  both the Weekly and May 1st $7 Calls, and that idea turned out to be a good one as well.

We’ve witnessed a trading range on the Weekly $7′s from .06 -.25, a whopping 316%, while the May 1st $7′s enjoyed an 87% run from .30 to .56.


Inovio Pharmaceuticals, Inc. INO 

INO stands among those stocks that we have covered the most over the years. An INO tag search of our archives yields no less than 30 results. We re-flagged it in yesterday’s premarket report and the timing was quite fortuitous.

Yesterday morning the company had announced it had been selected as the leader of a $45M DARPA program to develop practical treatments for the Ebola virus. It fueled a continued rise off of recent lows, and this morning’s news could contribute to that as well.  >> READ PR

INO heralded positive results from one of its studies, a DNA-based immunotherapy for the treatment of head and neck cancer. According to the CFO, the “initial data set from Inovio’s first cancer study provides encouraging evidence that we are on an important path to better optimized immunotherapy products.” >> READ PR

We’ll continue to keep watch over INO in the wake of these major developments.


Molycorp, Inc. MCP

MCP started showing up on our scanner back on March 23rd and 24th, when it was trading around .38. It retraced back to its 52-week low of .32 on the 27th.

After reappearing on our extended watchlist yesterday, it has traded as high as .62 in the premarket today; from a low of .484 that’s a 28% move up.

At .62, MCP had shown us a 94% overall move from its ultimate low set just the week before last. With gold and other precious metal prices on the rise again, we’ll continue to track MCP for more potential gain opportunities.


Rite-Aid Corp. RAD

We also wanted to make a quick mention of RAD. We tagged the stock for tracking back on December 4th and on that day we observed the lowest price the stock has traded at since then (5.48).

Since that time the stock has crept (and sometimes leaped) its way up the chart; it broke its 50DMA in early March, and managed break the $9-mark last Thursday, and then again yesterday. At Thursday’s high of 9.07, we had witnessed a total gain of 65%

Wall Street analysts are giving RAD high marks, and the stock is also receiving a 96% Overall “Buy” Rating at BARCHART.COM so we’ll certainly want to keep a close watch on RAD moving forward in the event that it sustains the bullish patterns it has been exhibiting over the past several months.


Extended Watchlist:
EXEL, OPXA, WPCS, MPET, MSTX, SLTD

Blue Horseshoe Stocks: ESPR Options, MVIS Recaps & More


Esperion Therapeutics, Inc. ESPR

ESPR found new highs once again yesterday for the second straight session after we initially tagged it for options trading potential on Tuesday.

In addition to monitoring Weekly In-the-money Calls, which yielded up the opportunity at gains ranging from 400-1400% on Tuesday, and continued their own runs yesterday, we also had specified a longer-term idea that continued to work extraordinarily well.

That idea, the 04/17 $90 Calls, traded from a low of 11.60 all the way up to 21.90 yesterday. It represented an excellent single-session intraday increase of 89%, and a whopping 525% jump over our observed low from Tuesday (3.50).

Big congratulations go out to any of our readers who reaped the benefits ESPR, which has easily emerged as our top target of the week! The stock is gapping up in the premarket this morning, so it appears as if we could see a further extension of those gains.


Microvision, Inc. MVIS

On Monday we tagged MVIS in a gap-up watchlist, and it has found its way into every one of our reports this week, setting new highs each day.

Yesterday the stock traded in a range from 3.42-4.23, a healthy intraday move of 24% From our observed low of 2.88 on Monday, that high marked a rise of 47% overall.

As you can see below, given the extremely over-bought look of the chart, now might be a good time to lock in any profits gained over the course of the week. This major move has been fueled by a PR out Monday in which the company announced orders totaling more than $14M it had received for components of its patented PicoP® display technology >> VIEW PR


Side Note:

Yesterday in advance of the FOMC Meeting, we cautioned readers to stay alert and watch for the effect that Janet Yellen’s commentary would have on the markets. To take advantage of this expected surge in either direction, we mentioned trading options calls on either the SPY, if the markets went up, or UVXY and/or VIX if they slid back.  Either way it played out, we said, we wanted “to stay in-the-money with our strike prices.”

As it turned out, the Fed announcement caused a sharp rise in the markets, and as a result the SPY Calls were the ones to play. We saw substantial gains on in-the-money Calls as the SPY spiked to $211.27.

For example, the SPY $209.50 Calls traded in a range from .80-2.00, for an intraday move totaling 150%  $210 Calls also spiked heavily from a low of .40 to as much as 1.59, a huge 297% jump.


Extended Watchlist:
FOLD, RAD, NQ, CNDO, SYN, SMLR

Blue Horseshoe Stocks: BCLI Recap & More

BrainStorm Cell Therapeutics, Inc. BCLI

2015 is upon us and our first order of business is to address one of the stocks we tagged in Wednesday’s premarket report. BCLI had a strong session, as it pushed its way up from an early low of 4.02 to an aftyernoon high of 4.94; a solid +23% performance.

The strong session was apparently aided by the pre-emptive PR the company released which served as a reminder that results from Phase 2a trials of its ALS (Lou Gehrig’s Disease) treatment would be released on Monday. This morning the stock is gapping up wildly as anticipation grows, having already hit a premarket high of 7.28, which represents a total increase of 81% over the low we observed on New Year’s Eve.

Monday’s data release, which is expected to be positive, should most likely produce one of two effects. Either the results will beat expectations and facilitate another strong move, or they will fail to meet the mark and cause a pullback. In case of the latter, there may be rebound opportunities waiting just around the corner.



RedHill BioPharma Ltd. RDHL & NephroGenex, Inc. NRX

We also had this pair of standouts appear in Wednesday’s report, with each stock making a similar move. Both started the day with significant spikes in PPS, followed by a tapering off into the close.

RDHL made a sensational jump beginning almost immediately at the open running from 12.52 on up to 17.85 before its pullback, an intraday spike equaling 42.5%. Coincidentally, the stock ended the session having traded 42.5X its 3-month average volume.

NRX
saw an initial low of 12.96, followed by a healthy 39% run to a high of 17.98. This play would offer one more opportunity in the form of an intraday swing as it came down and rebounded off of the 12.60-mark before returning to 15.15, an added 20% move, bringing the day’s cumulative total of possible gains to 59% .


Extended Watchlist:
CUR, ARWR, CLF, MSTX, RAD